Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

An alternative therapy against brucellosis

18.01.2006


Concepción Lecároz, a researcher from the University of Navarra, has developed a new therapy against brucellosis. This zoonosis —a disease or infection of animals which can be transmitted to humans under natural conditions— annually affects 500,000 people worldwide. This research project forms part of her doctoral thesis, defended at the University’s School of Pharmacy.



This study has permitted the development of a new treatment which significantly reduces infections in mice, as opposed to the traditional treatment with “free” (unencapsulated) antibiotics with short treatment times. Despite the fact that brucellosis is highly susceptible to the majority of antibiotics, the indices of relapse in humans ranges from 5 to 15% depending on the antibiotic regimen; in any case, standard treatment requires combined therapy during long periods of time.

The alternative treatment developed by Ms. Lecároz involves the transportation of the antibiotic gentamicina to infected cells by means of biodegradable particles, which can produce a much higher concentration of antibiotic precisely in the organs which are infected. These biodegradable systems are designed in such a way that they release the antibiotic in a controlled manner, which allows therapeutic levels of antibiotics after a reduced number of dosages.


The next step: human trials

In this research project, Concepción Lecároz has achieved a significant reduction of spleen pathogens in mice, which has led to the possibility of achieving similar results in humans.

In Spain, along with tuberculosis and meningococcal meningitis, brucellosis is one of the most frequent endemic bacterial pathologies. The characteristic symptoms of the disease are fever, chills, weakness, muscular pain, sweating and headaches. If the bacteria invades the bloodstream, it can infect numerous tissues and organs, such as the liver, the spleen, the bones, the genitourinary system, the lungs, the central nervous system, and the heart, to the point of even endangering the life of the patient.

Irati Kortabitarte | alfa
Further information:
http://www.basqueresearch.com/berria_irakurri.asp?Gelaxka=1_1&Berri_Kod=858&hizk=I

More articles from Life Sciences:

nachricht One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie

nachricht The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>